Log in to save to my catalogue

Predicting continuous amyloid PET values with CSF and plasma Aβ42/Aβ40

Predicting continuous amyloid PET values with CSF and plasma Aβ42/Aβ40

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_d35aeb97748f4861a204b2e53b510cbe

Predicting continuous amyloid PET values with CSF and plasma Aβ42/Aβ40

About this item

Full title

Predicting continuous amyloid PET values with CSF and plasma Aβ42/Aβ40

Publisher

United States: John Wiley & Sons, Inc

Journal title

Alzheimer's & dementia : diagnosis, assessment & disease monitoring, 2023-01, Vol.15 (1), p.e12405-n/a

Language

English

Formats

Publication information

Publisher

United States: John Wiley & Sons, Inc

More information

Scope and Contents

Contents

Introduction
Continuous measures of amyloid burden as measured by positron emission tomography (PET) are being used increasingly to stage Alzheimer's disease (AD). This study examined whether cerebrospinal fluid (CSF) and plasma amyloid beta (Aβ)42/Aβ40 could predict continuous values for amyloid PET.
Methods
CSF Aβ42 and Aβ40 were measure...

Alternative Titles

Full title

Predicting continuous amyloid PET values with CSF and plasma Aβ42/Aβ40

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_d35aeb97748f4861a204b2e53b510cbe

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_d35aeb97748f4861a204b2e53b510cbe

Other Identifiers

ISSN

2352-8729

E-ISSN

2352-8729

DOI

10.1002/dad2.12405

How to access this item